Avantor® Introduces New J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease

Avantor, Inc. (NYSE: AVTR), a leading global provider of critical products and services to the life sciences and advanced technologies industries, has unveiled two groundbreaking products designed to optimize the gene therapy harvest process sustainably: J.T.Baker® Cell Lysis Solution and…

Read MoreAvantor® Introduces New J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease

Probiotic Spore-forming Lactic Acid Bacteria Proven to Alleviate Cold-like Symptoms

Mitsubishi Chemical Corporation, part of the Mitsubishi Chemical Group, conducted a clinical study to verify the efficacy of the spore-forming lactic acid producing bacteria probiotic Heyndrickxia coagulans (formerly Weizmannia, Bacillus) coagulans (Heyndrickxia coagulans SANK70258) for alleviating cold-like symptoms in humans.…

Read MoreProbiotic Spore-forming Lactic Acid Bacteria Proven to Alleviate Cold-like Symptoms

Brenntag Specialties Nutrition Signs Exclusive Distribution Agreement for EpiCor with Cargill

Brenntag, the global leader in chemicals and ingredients distribution, has entered into an exclusive distribution agreement with American global food corporation Cargill, Inc., for EpiCor postbiotic. This agreement covers most parts of Europe, including the UK, Ireland, Italy, Spain, Portugal,…

Read MoreBrenntag Specialties Nutrition Signs Exclusive Distribution Agreement for EpiCor with Cargill

Westlake Innovations Partners with Blackhorn Ventures for Strategic Investment

Westlake Innovations, Inc., a subsidiary of Westlake Corporation (NYSE: WLK), has recently invested in the Blackhorn Industrial Impact Fund II, managed by Blackhorn Ventures. This strategic move reflects Westlake’s dedication to fostering a sustainable future by supporting innovative solutions in…

Read MoreWestlake Innovations Partners with Blackhorn Ventures for Strategic Investment

Culp Reports Fourth Quarter and Fiscal 2024 Results, Updates on Restructuring Efforts

Culp, Inc. Reports Fourth Quarter and Fiscal 2024 Results, Updates on Restructuring Initiatives Culp, Inc. (NYSE: CULP) (together with its consolidated subsidiaries, “CULP”) has announced its financial and operating results for the fourth quarter and fiscal year ended April 28,…

Read MoreCulp Reports Fourth Quarter and Fiscal 2024 Results, Updates on Restructuring Efforts